Zevra Therapeutics Inc ZVRA

US Pharmaceuticals

$9.51 ▼ -1.35% ($-0.13)

📅 Earnings This Week

Open $9.70

Prev Close $9.64

Day Range $9.34 – $9.75

52W Range $7.16 – $15.04

Market Cap $569.87M

P/E (TTM) 4.87

Beta 0.91

EPS (TTM) $2.15

📋 Company Profile

Industry	Pharmaceuticals
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2015-04-16
Shares Out.	59,120,000
Website	zevra.com/ ↗
Phone	13219393416
Employees	61
Revenue	$36.2M
Gross Profit	$34.3M
Net Income	$37.9M
Free Cash Flow	$12.0M
Total Assets	$278.6M
Total Liabilities	$72.8M
Equity	$205.8M

About Zevra Therapeutics Inc

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

Zevra Therapeutics Inc is a publicly traded company under the ticker symbol ZVRA on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.